{
    "clinical_study": {
        "@rank": "164833", 
        "arm_group": [
            {
                "arm_group_label": "Peri-implant mucosa", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "periodontal mucosa", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a pilot study. The investigators hypothesize that the peri-implant soft tissue\n      response to de novo plaque accumulation is similar to that of normal gingival tissue in the\n      same subjects.\n\n      The investigators propose to conduct a controlled clinical trial to evaluate peri-implant\n      soft tissue response to de novo plaque accumulation in comparison to the response of\n      gingival tissue in the same subjects"
        }, 
        "brief_title": "Experimental Peri-implant Mucositis in Humans", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Peri-implant Mucositis", 
            "Gingivitis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Gingivitis", 
                "Mucositis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -Male and Female \u00b321 years of age.\n\n        Oral site specific inclusion criteria:\n\n          -  1) Presence of 2 implants in the maxillary or mandibular  arch supporting fixed\n             restorations in function for at least 1 year (Test)\n\n          -  2) Presence of 2 teeth in the corresponding position of the implant (Control); -3)\n             Absence of active infections at both test and control sites\n\n          -  4) Absence of radiographic bone loss at both test and control sites\n\n          -  5) Pocket depth \u22644mm at both test and control sites\n\n          -  6) must give written informed consent.\n\n        Exclusion Criteria:\n\n          -  1) Treatment with antibiotics for any dental or medical condition within 1 month\n             before screening\n\n          -  2) Systemic diseases that require chronic use of anti-inflammatory medications,\n             antibiotics or anticoagulants\n\n          -  3) Ongoing medications for systemic conditions initiated <3 months before the start\n             of the study or the requirement to take prophylactic antibiotics for invasive dental\n             procedures\n\n          -  4) Significant organ disease including impaired kidney function, heart murmur,\n             rheumatic fever, bleeding disorder\n\n          -  5) Active infectious diseases such as hepatitis, tuberculosis and HIV\n\n          -  6) Clinically detectable caries and periodontal disease\n\n          -  7) Tobacco use of any kind\n\n          -  8)  Use of medications affecting periodontal status (diphenylhydantoin, cyclosporine\n             etc.)\n\n          -  9) No pregnancy or lactation or expectation to become pregnant within next 3 months.\n\n        Participants will be excluded from the study or analysis if any of the following occur\n        during the study: 1) Changes in the patient medical status or medications that met the\n        exclusion criteria; 2) Use of antimicrobial rinses; 3) Use of irrigating devices; 4)\n        Subject noncompliance with stent wearing during the experimental mucositis/gingivitis\n        phase and/or Vitamin C use; 5) Use of anti-inflammatory drugs or antibiotics; 6) allergic\n        history to common toothpaste or mouth rinse ingredients.\n\n        Acute use of acetaminophen will be permitted."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01941797", 
            "org_study_id": "cro-2011perio-02-fp"
        }, 
        "intervention": {
            "arm_group_label": [
                "Peri-implant mucosa", 
                "periodontal mucosa"
            ], 
            "intervention_name": "interruption of oral hygiene", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 12, 2013", 
        "link": {
            "description": "University of Connecticut Health center Clinical Trials", 
            "url": "http://home2.uchc.edu/Starr/Study/Condition/Details.aspx?Condition=47"
        }, 
        "location": {
            "contact": {
                "email": "mclement@uchc.edu", 
                "last_name": "Megyn L Clement, CDA", 
                "phone": "860-679-4995", 
                "phone_ext": "4995"
            }, 
            "facility": {
                "address": {
                    "city": "Farmington", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06030"
                }, 
                "name": "University of Connecticut Health Center"
            }, 
            "investigator": {
                "last_name": "Gian Pietro Schincaglia, DDS,PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Experimental Peri-implant Mucositis in Humans", 
        "overall_contact": {
            "email": "schincaglia@uchc.edu", 
            "last_name": "Gian Pietro Schincaglia, DDS,PhD", 
            "phone": "860 679 2258", 
            "phone_ext": "2258"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The gingival crevicular fluid ( GCF) volume is assessed using Periotron unit. The GCF volume  is strongly correlated with peri-implant mucosa and gingival inflammation.", 
            "measure": "Gingival Crevicular fluid volume collected at baseline and weekly up to 9 weeks", 
            "safety_issue": "No", 
            "time_frame": "9 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01941797"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Connecticut Health Center", 
            "investigator_full_name": "Gian Schincaglia", 
            "investigator_title": "Clinical Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Connecticut Health Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Colgate Palmolive Co.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Connecticut Health Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}